Results 121 to 130 of about 36,891 (208)

Apixaban versus enoxaparin to prevent venous thromboembolism in post-operative patients with gynecologic cancers at an urban academic medical center

Gynecologic Oncology Reports
Objective: A recent clinical trial demonstrated that the use of apixaban was safe and equal to enoxaparin (LMWH) in post-operative gynecologic oncology patients.
Victoria Diamond, Katherine Gerber, Geno Merli, Rebecca Mercier, Aaron Shafer, Norman Rosenblum   +5 more
doaj   +1 more source

Novel oral anticoagulants: focus on stroke prevention and treatment of venous thrombo-embolism [PDF]

, 2017
Anticoagulation for the long-term treatment and prevention of thrombo-embolic diseases as well as for stroke prevention in atrial fibrillation (AF) has been accomplished by vitamin K antagonists for the last half century. Although effective under optimal
Braunwald, Eugene, Steffel, Jan
core  

Dependence of clot structure and fibrinolysis on apixaban and clotting activator

Research and Practice in Thrombosis and Haemostasis
Background: Anticoagulants prevent the formation of potentially fatal blood clots. Apixaban is a direct oral anticoagulant that inhibits factor (F)Xa, thereby impeding the conversion of prothrombin into thrombin and the formation of blood clots.
Rebecca A. Risman, Mitali Shroff, Julie Goswami, Valerie Tutwiler   +3 more
doaj   +1 more source

Apixaban plasma concentrations before and after catheter ablation for atrial fibrillation.

PLoS ONE
BackgroundCatheter ablation in patients with atrial fibrillation is associated with a transient increase in thromboembolic risk and adequate anticoagulation is highly important.
Rachel Aakerøy, Jan Pål Loennechen, Roar Dyrkorn, Stian Lydersen, Arne Helland, Olav Spigset   +5 more
doaj   +1 more source

Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence

Drug Design, Development and Therapy, 2014
Ali Zalpour,1 Thein Hlaing Oo21Division of Pharmacy – Clinical Programs, 2Section of Thrombosis and Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX, USAAbstract: Anticoagulation with heparin and vitamin K ...
Zalpour A, Oo TH
doaj  

Contemporary management of atrial fibrillation: what can clinical registries tell us about stroke prevention and current therapeutic approaches? [PDF]

, 2014
Al-Khatib, SM, Banerjee, A, Blendea, D, Camm, AJ, Conroy, JM, Cosio, FG, De Bono, J, G Cosio, MD, Guasch, E, Halperin, JL, Hess, PL, Kirchhof, P, Lip, GY, Nattel, S, Ruskin, J, Savelieva, I   +15 more
core   +1 more source

Safety and efficacy of apixaban versus enoxaparin in gynecologic cancer patients undergoing open surgery: an open-label randomized controlled trial. [PDF]

Thromb J
Aminimoghaddam S, Mohazzab A, Pourali R, Zendehdel H.   +3 more
europepmc   +1 more source

Use of Apixaban for Venous Thromboembolism Prophylaxis in an Older Hemodialysis Patient After Total Knee Replacement: A Case Report. [PDF]

Am J Case Rep
Alanizi AH, Alanazi NH, Bin Makhash AS, Alotibi RH, Qubaiban RM, Badawoud AM, AlSaati MF.   +6 more
europepmc   +1 more source

Comparative Effectiveness of Oral Anticoagulants and Home Time After Venous Thromboembolism in Frail and Non-Frail Older Adults. [PDF]

Am J Hematol
Park CM, Shi S, Chen X, Parks AL, Kim DH.   +4 more
europepmc   +1 more source

Possible Right Coronary Artery Supply to Pericardial Adipose Tissue Adjacent to an Abnormal Proximal Ascending Aortic Wall: A Case Report. [PDF]

Cureus
Takeuchi H.
europepmc   +1 more source